CA2548347A1 - Procedes pour generer une immunite a un antigene - Google Patents

Procedes pour generer une immunite a un antigene Download PDF

Info

Publication number
CA2548347A1
CA2548347A1 CA002548347A CA2548347A CA2548347A1 CA 2548347 A1 CA2548347 A1 CA 2548347A1 CA 002548347 A CA002548347 A CA 002548347A CA 2548347 A CA2548347 A CA 2548347A CA 2548347 A1 CA2548347 A1 CA 2548347A1
Authority
CA
Canada
Prior art keywords
antigen
vector
ligand
protein
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002548347A
Other languages
English (en)
Inventor
Albert Deisseroth
Yucheng Tang
Xiang-Ming Fang
Wei-Wei Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sidney Kimmel Cancer Center
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2548347A1 publication Critical patent/CA2548347A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
CA002548347A 2003-12-11 2004-12-10 Procedes pour generer une immunite a un antigene Abandoned CA2548347A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59201603P 2003-12-11 2003-12-11
US60/529,016 2003-12-11
PCT/US2004/041690 WO2005058950A2 (fr) 2003-12-11 2004-12-10 Procedes pour generer une immunite a un antigene

Publications (1)

Publication Number Publication Date
CA2548347A1 true CA2548347A1 (fr) 2005-06-30

Family

ID=34700248

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002548347A Abandoned CA2548347A1 (fr) 2003-12-11 2004-12-10 Procedes pour generer une immunite a un antigene

Country Status (3)

Country Link
EP (1) EP1720905A2 (fr)
CA (1) CA2548347A1 (fr)
WO (1) WO2005058950A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061414A1 (fr) * 2004-12-09 2006-06-15 Ingenium Pharmaceuticals Ag Procedes et agents utilises dans le traitement d'etats caracterises par l'hyperproduction/ hypersecretion de mucus
JP2009514536A (ja) 2005-11-07 2009-04-09 シドニー キンメル キャンサー センター Ｃｄ４０リガンド融合蛋白質ワクチン
EP2517723B1 (fr) 2006-09-18 2019-11-06 The Board of Trustees of The University of Arkansas Compositions et procédés d'amélioration des réponses immunitaires
US10174100B1 (en) * 2006-11-06 2019-01-08 Microvax, Llc Multivalent DNA composition for Yersinia pestis
EP3061462B1 (fr) 2007-07-02 2019-02-27 Etubics Corporation Procédés et compositions permettant de produire un vecteur d'adénovirus destiné à être utilisé avec des vaccinations multiples
BRPI0818736A2 (pt) 2007-10-30 2017-06-13 Univ Arkansas composições e métodos para intensificar imunorrepostas à bactéria flagelada
HUE047164T2 (hu) 2007-11-01 2020-04-28 Univ Arkansas Kompozíciók és eljárások eimeria elleni immunválasz fokozására
EP2525817B8 (fr) 2010-01-21 2017-09-20 The Board of Trustees of The University of Arkansas Vecteurs de vaccin et procédés d'amplification de réponses immunitaires
HUE046858T2 (hu) 2010-06-09 2020-03-30 Univ Arkansas Vakcina és eljárások campylobacter fertõzés csökkentésére
US9605276B2 (en) 2012-08-24 2017-03-28 Etubics Corporation Replication defective adenovirus vector in vaccination
MY173328A (en) 2013-02-14 2020-01-16 Texas A & M Univ Sys Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
EA033538B1 (ru) 2013-03-15 2019-10-31 Univ Arkansas Композиции и способы усиления иммунного ответа на кишечные патогены
CN104345152B (zh) * 2013-08-08 2016-09-21 中国人民解放军第二军医大学东方肝胆外科医院 MUC15与p-AKT在制备肝癌预后评估试剂盒中的应用
CN107530383A (zh) 2015-01-09 2018-01-02 埃图比克斯公司 用于埃博拉病毒疫苗接种的方法和组合物
JP6647315B2 (ja) 2015-01-09 2020-02-14 イーチュービクス コーポレイション 組み合わせ免疫療法のための方法および組成物
RU2714157C2 (ru) * 2015-02-06 2020-02-12 Хит Байолоджикс, Инк. Вектор, коэкспрессирующий молекулы для вакцинации и костимулирующие молекулы
US11149087B2 (en) 2015-04-20 2021-10-19 Etubics Corporation Methods and compositions for combination immunotherapy
TWI758288B (zh) 2016-05-03 2022-03-21 阿肯色州大學董事會 包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法
WO2018071405A1 (fr) 2016-10-11 2018-04-19 University Of Miami Vecteurs et cellules de vaccin pour immunité contre le virus zika
CA3058938A1 (fr) 2017-04-04 2018-10-11 Heat Biologics, Inc. Vaccination intratumorale

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2399790C (fr) * 2000-02-02 2012-10-30 Ralph A. Tripp Adjuvant du ligand cd40 destine au virus respiratoire syncytial

Also Published As

Publication number Publication date
WO2005058950A2 (fr) 2005-06-30
WO2005058950A3 (fr) 2006-03-02
EP1720905A2 (fr) 2006-11-15

Similar Documents

Publication Publication Date Title
US9353167B2 (en) Methods for generating immunity to antigen
US9757438B2 (en) Mucin antigen vaccine
US20060286074A1 (en) Methods for immunotherapy of cancer
CA2548347A1 (fr) Procedes pour generer une immunite a un antigene
US7662586B2 (en) Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
US8119117B2 (en) Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity
JP2005503791A (ja) エクソゾームにタンパク質を標的化する方法および組成物
WO2019101062A1 (fr) Vaccin recombiné et son application
WO2008012237A1 (fr) Construction de multiples antigènes et leur utilisation
JP2008504219A (ja) 抗原に対する免疫を生じさせる方法
US20060286114A1 (en) Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
JP2005526511A (ja) ワクチン

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued